# Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/larotrectinib-in-patients-with-trk-fusion-positive-solid-tumours-a-pooled/

## Facts

| Field | Value |
| --- | --- |
| Author Names | David S. Hong,Steven G. DuBois,Shivaani Kummar,Anna F. Farago,Catherine M. Albert,Kristoffer Staal Rohrberg,Cornelis M. van Tilburg,Ramamoorthy Nagasubramanian,Jordan Berlin,Noah Federman,Leo Mascarenhas,Birgit Geoerger,Afshin Dowlati,Alberto S. Pappo,Stefan Bielack,François Doz,Ray McDermott,Jyoti D. Patel,Russell J. Schilder,Makoto Tahara,Stefan M. Pfister,Olaf Witt,Marc Ladanyi,Erin R. Rudzinski,Shivani Nanda,Barrett H. Childs,Theodore W. Laetsch,David M. Hyman,Alexander Drilon |
| Citations | 1,009 |
| DOI | 10.1016/s1470-2045(19)30856-3 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/7497841 |
| OpenAlex ID | https://openalex.org/W3008107700 |
| PMID | 32105622 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Afshin Dowlati](https://scholariq.org/researchers/afshin-dowlati/)
- [Marc Ladanyi](https://scholariq.org/researchers/marc-ladanyi/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Chromatin Remodeling and Cancer](https://scholariq.org/topics/chromatin-remodeling-and-cancer/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.